| Dr Dawn Laverne Ramdas, DO | |
|
502 E 2nd St, Duluth, MN 55805-1913 | |
| (218) 786-8364 | |
| Not Available |
| Full Name | Dr Dawn Laverne Ramdas |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 502 E 2nd St, Duluth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801393434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 125.075226 (Illinois) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 73478 (Minnesota) | Primary |
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia.
Tobacco is the leading underlying single cause of death worldwide. In 2016, tobacco use caused over 7.1 million deaths mostly related to lung and heart disease, cancer, and stroke. Every year, on May 31, people and organizations mark World No Tobacco Day, by highlighting the health and other risks associated with tobacco use and advocating for effective policies to reduce tobacco consumption.
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease. In addition, the international research team pinpointed two areas along stretches of DNA that play an important role in regulating gene activity associated with the arthritic condition.
Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has entered into an exclusive agreement with a large US specialty pharmaceutical distributor company for the distribution of its flagship product, intravenous alpha-1 antitrypsin (AAT-IV) in the United States.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dawn Laverne Ramdas, DO 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 | Dr Dawn Laverne Ramdas, DO 502 E 2nd St, Duluth, MN 55805-1913 Ph: (218) 786-8364 |
News Archive
Advances in rapid screening of leukemia cells for drug susceptibility and resistance are bringing scientists closer to patient-tailored treatment for acute myeloid leukemia.
Tobacco is the leading underlying single cause of death worldwide. In 2016, tobacco use caused over 7.1 million deaths mostly related to lung and heart disease, cancer, and stroke. Every year, on May 31, people and organizations mark World No Tobacco Day, by highlighting the health and other risks associated with tobacco use and advocating for effective policies to reduce tobacco consumption.
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease. In addition, the international research team pinpointed two areas along stretches of DNA that play an important role in regulating gene activity associated with the arthritic condition.
Kamada (TASE:KMDA), a bio-pharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has entered into an exclusive agreement with a large US specialty pharmaceutical distributor company for the distribution of its flagship product, intravenous alpha-1 antitrypsin (AAT-IV) in the United States.
› Verified 4 days ago
Chena Margaret-filizetti Beauduy, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-3925 | |
Gary Wayne Beaver, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Brian Wasserman, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Ricci Lee Bender, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 502 E 2nd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Timothy John Egan, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. Kenneth Alcuin Bromen, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 306 W Superior St, Suite 403, Duluth, MN 55802 Phone: 217-722-4379 Fax: 218-722-4333 | |
Erika Nicole Heard, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 502 E 2nd St, Duluth, MN 55805 Phone: 218-786-8376 |